Michael Thibault, PA
Family Medicine · Danbury, CTNPI 1659324515
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 669 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,892, more than ten times the $150 reported in 2019. Among family medicine clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 669 payments — averaging $21.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$1K
- Regeneron Healthcare Solutions, Inc.$1K
- Sun Pharmaceutical Industries Inc.$1K
- Pfizer$990
- Novartis$779
- plus $6K from 28 others
What the payments were for
- Food & beverage$13,76497%
- Education$4573%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 174 | $3,225 |
| Johnson & Johnson | 45 | $1,307 |
| Regeneron Healthcare Solutions, Inc. | 46 | $1,277 |
| Sun Pharmaceutical Industries Inc. | 54 | $1,041 |
| Pfizer | 56 | $990 |
| Novartis | 43 | $779 |
| Lilly USA, LLC | 31 | $669 |
| Incyte Corporation | 27 | $635 |
| LEO Pharma Inc. | 30 | $571 |
| Amgen | 27 | $546 |
| UCB, Inc. | 18 | $525 |
| Arcutis Biotherapeutics, Inc. | 24 | $504 |
| Galderma Laboratories, L.p. | 18 | $293 |
| Sanofi | 11 | $266 |
| Dermavant Sciences, Inc. | 11 | $263 |
| E.r. Squibb & Sons, L.L.C. | 7 | $166 |
| Organon | 5 | $119 |
| Botanix SB Inc | 5 | $117 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $104 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Blueprint Medicines Corporation | 3 | $96 |
| Biofrontera Inc. | 3 | $92 |
| DUSA Pharmaceuticals, Inc. | 4 | $90 |
| Strata Skin Sciences, Inc. | 4 | $69 |
| Mayne Pharma Commercial LLC | 3 | $66 |
| Verrica Pharmaceuticals Inc. | 3 | $61 |
| Fresenius Kabi USA, LLC | 2 | $51 |
| Boehringer Ingelheim | 2 | $46 |
| Almirall LLC | 2 | $38 |
| EPI Health, LLC | 1 | $29 |
| Medtronic | 1 | $25 |
| LNHC, Inc | 1 | $25 |
| Journey Medical Corporation | 1 | $18 |
| Genentech USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,220 in reported general payments places this provider in the 95th percentile of 588 family medicine providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 77 | $293,578 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 12 | $115,505 |
| Doxycycline Hyclate | 53 | $5,617 |
| Tacrolimus | 23 | $2,761 |
| Clobetasol Propionate | 70 | $2,123 |
| Fluocinonide | 46 | $2,055 |
| Metronidazole | 26 | $1,053 |
| Fluorouracil | 13 | $1,015 |
| Ciclopirox | 26 | $903 |
| Triamcinolone Acetonide | 111 | $881 |
| Ketoconazole | 65 | $769 |
| Clindamycin Phosphate | 20 | $718 |
| Desonide | 29 | $591 |
| Mupirocin | 46 | $270 |
| Econazole Nitrate | 21 | $248 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Danbury
- Theodore BrunoDurham$201K
- Kenneth DardickStorrs$146K
- Raymond KurkerSouth Windsor$107K
- Thao DoranMarlborough$102K
- Raja FattalehPutnam$53K
- Nicholas TzikasNew Haven$46K
- Helar CamposNew London$29K
- Kristin GianniniVernon$28K
- Sanjeev RaoBridgeport$27K
- Michael BeyVernon Rockville$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.